APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epoprostenol

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Epoprostenol Market Analysis and Forecast 2026-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchEpoprostenol Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Epoprostenol Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Epoprostenol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epoprostenol Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Epoprostenol Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Epoprostenol market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Epoprostenol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Epoprostenol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Epoprostenol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Epoprostenol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Epoprostenol include Teva Parenteral, Merck, Glaxosmithkline Inc, Bayer AG, SteadyMed, Sandoz Canada Incorporated, Reata Pharmaceuticals, Arena Pharmaceuticals and Actelion, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Epoprostenol, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Epoprostenol, also provides the sales of main regions and countries. Of the upcoming market potential for Epoprostenol, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Epoprostenol sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Epoprostenol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Epoprostenol sales, projected growth trends, production technology, application and end-user industry.

Epoprostenol Segment by Company

Teva Parenteral

Merck

Glaxosmithkline Inc

Bayer AG

SteadyMed

Sandoz Canada Incorporated

Reata Pharmaceuticals

Arena Pharmaceuticals

Actelion

Epoprostenol Segment by Type

Oral Epoprostenol

Injection Epoprostenol

Epoprostenol Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Epoprostenol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epoprostenol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epoprostenol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epoprostenol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Epoprostenol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Epoprostenol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epoprostenol sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Epoprostenol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Epoprostenol Major Manufacturers Table 3. Injection Epoprostenol Major Manufacturers Table 4. Global Epoprostenol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacy Major Manufacturers Table 6. Online Pharmacy Major Manufacturers Table 7. Hospital Pharmacy Major Manufacturers Table 8. Epoprostenol Industry Trends Table 9. Epoprostenol Industry Drivers Table 10. Epoprostenol Industry Opportunities and Challenges Table 11. Epoprostenol Industry Restraints Table 12. Global Epoprostenol Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Epoprostenol Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Epoprostenol Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Epoprostenol Revenue Market Share by Region (2021-2026) Table 16. Global Epoprostenol Revenue Market Share by Region (2027-2032) Table 17. Global Epoprostenol Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 18. Global Epoprostenol Sales by Region (2021-2026) & (tons) Table 19. Global Epoprostenol Sales by Region (2027-2032) & (tons) Table 20. Global Epoprostenol Sales Market Share by Region (2021-2026) Table 21. Global Epoprostenol Sales Market Share by Region (2027-2032) Table 22. Global Epoprostenol Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Epoprostenol Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Epoprostenol Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Epoprostenol Sales Market Share by Manufacturers (2021-2026) Table 26. Global Epoprostenol Sales Price (US$/ton) of Manufacturers (2021-2026) Table 27. Global Epoprostenol Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Epoprostenol Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Epoprostenol Manufacturers, Product Type & Application Table 30. Global Epoprostenol Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Epoprostenol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Epoprostenol Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Epoprostenol Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Epoprostenol Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Epoprostenol Revenue Market Share by Type (2021-2026) Table 37. Global Epoprostenol Revenue Market Share by Type (2027-2032) Table 38. Global Epoprostenol Sales by Type 2021 VS 2025 VS 2032 (tons) Table 39. Global Epoprostenol Sales by Type (2021-2026) & (tons) Table 40. Global Epoprostenol Sales by Type (2027-2032) & (tons) Table 41. Global Epoprostenol Sales Market Share by Type (2021-2026) Table 42. Global Epoprostenol Sales Market Share by Type (2027-2032) Table 43. Global Epoprostenol Price by Type (2021-2026) & (US$/ton) Table 44. Global Epoprostenol Price by Type (2027-2032) & (US$/ton) Table 45. Global Epoprostenol Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Epoprostenol Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Epoprostenol Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Epoprostenol Revenue Market Share by Application (2021-2026) Table 49. Global Epoprostenol Revenue Market Share by Application (2027-2032) Table 50. Global Epoprostenol Sales by Application 2021 VS 2025 VS 2032 (tons) Table 51. Global Epoprostenol Sales by Application (2021-2026) & (tons) Table 52. Global Epoprostenol Sales by Application (2027-2032) & (tons) Table 53. Global Epoprostenol Sales Market Share by Application (2021-2026) Table 54. Global Epoprostenol Sales Market Share by Application (2027-2032) Table 55. Global Epoprostenol Price by Application (2021-2026) & (US$/ton) Table 56. Global Epoprostenol Price by Application (2027-2032) & (US$/ton) Table 57. Teva Parenteral Company Information Table 58. Teva Parenteral Business Overview Table 59. Teva Parenteral Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 60. Teva Parenteral Epoprostenol Product Portfolio Table 61. Teva Parenteral Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 65. Merck Epoprostenol Product Portfolio Table 66. Merck Recent Development Table 67. Glaxosmithkline Inc Company Information Table 68. Glaxosmithkline Inc Business Overview Table 69. Glaxosmithkline Inc Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 70. Glaxosmithkline Inc Epoprostenol Product Portfolio Table 71. Glaxosmithkline Inc Recent Development Table 72. Bayer AG Company Information Table 73. Bayer AG Business Overview Table 74. Bayer AG Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Bayer AG Epoprostenol Product Portfolio Table 76. Bayer AG Recent Development Table 77. SteadyMed Company Information Table 78. SteadyMed Business Overview Table 79. SteadyMed Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. SteadyMed Epoprostenol Product Portfolio Table 81. SteadyMed Recent Development Table 82. Sandoz Canada Incorporated Company Information Table 83. Sandoz Canada Incorporated Business Overview Table 84. Sandoz Canada Incorporated Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Sandoz Canada Incorporated Epoprostenol Product Portfolio Table 86. Sandoz Canada Incorporated Recent Development Table 87. Reata Pharmaceuticals Company Information Table 88. Reata Pharmaceuticals Business Overview Table 89. Reata Pharmaceuticals Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Reata Pharmaceuticals Epoprostenol Product Portfolio Table 91. Reata Pharmaceuticals Recent Development Table 92. Arena Pharmaceuticals Company Information Table 93. Arena Pharmaceuticals Business Overview Table 94. Arena Pharmaceuticals Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Arena Pharmaceuticals Epoprostenol Product Portfolio Table 96. Arena Pharmaceuticals Recent Development Table 97. Actelion Company Information Table 98. Actelion Business Overview Table 99. Actelion Epoprostenol Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. Actelion Epoprostenol Product Portfolio Table 101. Actelion Recent Development Table 102. North America Epoprostenol Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Epoprostenol Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Epoprostenol Sales by Type (2021-2026) & (tons) Table 105. North America Epoprostenol Sales by Type (2027-2032) & (tons) Table 106. North America Epoprostenol Sales Price by Type (2021-2026) & (US$/ton) Table 107. North America Epoprostenol Sales Price by Type (2027-2032) & (US$/ton) Table 108. North America Epoprostenol Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Epoprostenol Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Epoprostenol Sales by Application (2021-2026) & (tons) Table 111. North America Epoprostenol Sales by Application (2027-2032) & (tons) Table 112. North America Epoprostenol Sales Price by Application (2021-2026) & (US$/ton) Table 113. North America Epoprostenol Sales Price by Application (2027-2032) & (US$/ton) Table 114. North America Epoprostenol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Epoprostenol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Epoprostenol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Epoprostenol Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 118. North America Epoprostenol Sales by Country (2021-2026) & (tons) Table 119. North America Epoprostenol Sales by Country (2027-2032) & (tons) Table 120. North America Epoprostenol Sales Price by Country (2021-2026) & (US$/ton) Table 121. North America Epoprostenol Sales Price by Country (2027-2032) & (US$/ton) Table 122. United States Epoprostenol Revenue (2021-2032) & (US$ Million) Table 123. Canada Epoprostenol Revenue (2021-2032) & (US$ Million) Table 124. Mexico Epoprostenol Revenue (2021-2032) & (US$ Million) Table 125. Europe Epoprostenol Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Epoprostenol Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Epoprostenol Sales by Type (2021-2026) & (tons) Table 128. Europe Epoprostenol Sales by Type (2027-2032) & (tons) Table 129. Europe Epoprostenol Sales Price by Type (2021-2026) & (US$/ton) Table 130. Europe Epoprostenol Sales Price by Type (2027-2032) & (US$/ton) Table 131. Europe Epoprostenol Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Epoprostenol Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Epoprostenol Sales by Application (2021-2026) & (tons) Table 134. Europe Epoprostenol Sales by Application (2027-2032) & (tons) Table 135. Europe Epoprostenol Sales Price by Application (2021-2026) & (US$/ton) Table 136. Europe Epoprostenol Sales Price by Application (2027-2032) & (US$/ton) Table 137. Europe Epoprostenol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Epoprostenol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Europe Epoprostenol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Europe Epoprostenol Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 141. Europe Epoprostenol Sales by Country (2021-2026) & (tons) Table 142. Europe Epoprostenol Sales by Country (2027-2032) & (tons) Table 143. Europe Epoprostenol Sales Price by Country (2021-2026) & (US$/ton) Table 144. Europe Epoprostenol Sales Price by Country (2027-2032) & (US$/ton) Table 145. Germany Epoprostenol Revenue (2021-2032) & (US$ Million) Table 146. France Epoprostenol Revenue (2021-2032) & (US$ Million) Table 147. U.K. Epoprostenol Revenue (2021-2032) & (US$ Million) Table 148. Italy Epoprostenol Revenue (2021-2032) & (US$ Million) Table 149. Russia Epoprostenol Revenue (2021-2032) & (US$ Million) Table 150. Spain Epoprostenol Revenue (2021-2032) & (US$ Million) Table 151. Netherlands Epoprostenol Revenue (2021-2032) & (US$ Million) Table 152. Switzerland Epoprostenol Revenue (2021-2032) & (US$ Million) Table 153. Sweden Epoprostenol Revenue (2021-2032) & (US$ Million) Table 154. Poland Epoprostenol Revenue (2021-2032) & (US$ Million) Table 155. China Epoprostenol Revenue by Type (2021-2026) & (US$ Million) Table 156. China Epoprostenol Revenue by Type (2027-2032) & (US$ Million) Table 157. China Epoprostenol Sales by Type (2021-2026) & (tons) Table 158. China Epoprostenol Sales by Type (2027-2032) & (tons) Table 159. China Epoprostenol Sales Price by Type (2021-2026) & (US$/ton) Table 160. China Epoprostenol Sales Price by Type (2027-2032) & (US$/ton) Table 161. China Epoprostenol Revenue by Application (2021-2026) & (US$ Million) Table 162. China Epoprostenol Revenue by Application (2027-2032) & (US$ Million) Table 163. China Epoprostenol Sales by Application (2021-2026) & (tons) Table 164. China Epoprostenol Sales by Application (2027-2032) & (tons) Table 165. China Epoprostenol Sales Price by Application (2021-2026) & (US$/ton) Table 166. China Epoprostenol Sales Price by Application (2027-2032) & (US$/ton) Table 167. Asia Epoprostenol Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Epoprostenol Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Epoprostenol Sales by Type (2021-2026) & (tons) Table 170. Asia Epoprostenol Sales by Type (2027-2032) & (tons) Table 171. Asia Epoprostenol Sales Price by Type (2021-2026) & (US$/ton) Table 172. Asia Epoprostenol Sales Price by Type (2027-2032) & (US$/ton) Table 173. Asia Epoprostenol Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Epoprostenol Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Epoprostenol Sales by Application (2021-2026) & (tons) Table 176. Asia Epoprostenol Sales by Application (2027-2032) & (tons) Table 177. Asia Epoprostenol Sales Price by Application (2021-2026) & (US$/ton) Table 178. Asia Epoprostenol Sales Price by Application (2027-2032) & (US$/ton) Table 179. Asia Epoprostenol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Epoprostenol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Epoprostenol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Epoprostenol Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 183. Asia Epoprostenol Sales by Country (2021-2026) & (tons) Table 184. Asia Epoprostenol Sales by Country (2027-2032) & (tons) Table 185. Asia Epoprostenol Sales Price by Country (2021-2026) & (US$/ton) Table 186. Asia Epoprostenol Sales Price by Country (2027-2032) & (US$/ton) Table 187. Japan Epoprostenol Revenue (2021-2032) & (US$ Million) Table 188. South Korea Epoprostenol Revenue (2021-2032) & (US$ Million) Table 189. India Epoprostenol Revenue (2021-2032) & (US$ Million) Table 190. Australia Epoprostenol Revenue (2021-2032) & (US$ Million) Table 191. Taiwan Epoprostenol Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Epoprostenol Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Epoprostenol Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Epoprostenol Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Epoprostenol Sales by Type (2021-2026) & (tons) Table 196. SAMEA Epoprostenol Sales by Type (2027-2032) & (tons) Table 197. SAMEA Epoprostenol Sales Price by Type (2021-2026) & (US$/ton) Table 198. SAMEA Epoprostenol Sales Price by Type (2027-2032) & (US$/ton) Table 199. SAMEA Epoprostenol Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Epoprostenol Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Epoprostenol Sales by Application (2021-2026) & (tons) Table 202. SAMEA Epoprostenol Sales by Application (2027-2032) & (tons) Table 203. SAMEA Epoprostenol Sales Price by Application (2021-2026) & (US$/ton) Table 204. SAMEA Epoprostenol Sales Price by Application (2027-2032) & (US$/ton) Table 205. SAMEA Epoprostenol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Epoprostenol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Epoprostenol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Epoprostenol Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 209. SAMEA Epoprostenol Sales by Country (2021-2026) & (tons) Table 210. SAMEA Epoprostenol Sales by Country (2027-2032) & (tons) Table 211. SAMEA Epoprostenol Sales Price by Country (2021-2026) & (US$/ton) Table 212. SAMEA Epoprostenol Sales Price by Country (2027-2032) & (US$/ton) Table 213. Brazil Epoprostenol Revenue (2021-2032) & (US$ Million) Table 214. Argentina Epoprostenol Revenue (2021-2032) & (US$ Million) Table 215. Chile Epoprostenol Revenue (2021-2032) & (US$ Million) Table 216. Colombia Epoprostenol Revenue (2021-2032) & (US$ Million) Table 217. Peru Epoprostenol Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Epoprostenol Revenue (2021-2032) & (US$ Million) Table 219. Israel Epoprostenol Revenue (2021-2032) & (US$ Million) Table 220. UAE Epoprostenol Revenue (2021-2032) & (US$ Million) Table 221. Turkey Epoprostenol Revenue (2021-2032) & (US$ Million) Table 222. Iran Epoprostenol Revenue (2021-2032) & (US$ Million) Table 223. Egypt Epoprostenol Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Epoprostenol Distributors List Table 227. Epoprostenol Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Epoprostenol Image Figure 2. Global Epoprostenol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epoprostenol Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Epoprostenol Image Figure 5. Injection Epoprostenol Image Figure 6. Global Epoprostenol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Epoprostenol Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacy Image Figure 9. Online Pharmacy Image Figure 10. Hospital Pharmacy Image Figure 11. Global Epoprostenol Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Epoprostenol Revenue (2021-2032) & (US$ Million) Figure 13. Global Epoprostenol Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Epoprostenol Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Epoprostenol Revenue Market Share by Region (2021-2032) Figure 16. Global Epoprostenol Sales (2021-2032) & (tons) Figure 17. Global Epoprostenol Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 18. Global Epoprostenol Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Epoprostenol Sales YoY (2021-2032) & (tons) Figure 20. Europe Epoprostenol Sales YoY (2021-2032) & (tons) Figure 21. China Epoprostenol Sales YoY (2021-2032) & (tons) Figure 22. Asia (Excluding China) Epoprostenol Sales YoY (2021-2032) & (tons) Figure 23. South America, Middle East and Africa Epoprostenol Sales YoY (2021-2032) & (tons) Figure 24. Global Epoprostenol Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Epoprostenol Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Epoprostenol Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Epoprostenol Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Epoprostenol Revenue Market Share by Type (2021-2032) Figure 30. Global Epoprostenol Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 31. Global Epoprostenol Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Epoprostenol Sales Market Share by Type (2021-2032) Figure 33. Global Epoprostenol Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Epoprostenol Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Epoprostenol Revenue Market Share by Application (2021-2032) Figure 36. Global Epoprostenol Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 37. Global Epoprostenol Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Epoprostenol Sales Market Share by Application (2021-2032) Figure 39. North America Epoprostenol Revenue Share by Type (2021-2032) Figure 40. North America Epoprostenol Sales Share by Type (2021-2032) Figure 41. North America Epoprostenol Revenue Share by Application (2021-2032) Figure 42. North America Epoprostenol Sales Share by Application (2021-2032) Figure 43. North America Epoprostenol Revenue Share by Country (2021-2032) Figure 44. North America Epoprostenol Sales Share by Country (2021-2032) Figure 45. Europe Epoprostenol Revenue Share by Type (2021-2032) Figure 46. Europe Epoprostenol Sales Share by Type (2021-2032) Figure 47. Europe Epoprostenol Revenue Share by Application (2021-2032) Figure 48. Europe Epoprostenol Sales Share by Application (2021-2032) Figure 49. Europe Epoprostenol Revenue Share by Country (2021-2032) Figure 50. Europe Epoprostenol Sales Share by Country (2021-2032) Figure 51. China Epoprostenol Revenue Share by Type (2021-2032) Figure 52. China Epoprostenol Sales Share by Type (2021-2032) Figure 53. China Epoprostenol Revenue Share by Application (2021-2032) Figure 54. China Epoprostenol Sales Share by Application (2021-2032) Figure 55. Asia Epoprostenol Revenue Share by Type (2021-2032) Figure 56. Asia Epoprostenol Sales Share by Type (2021-2032) Figure 57. Asia Epoprostenol Revenue Share by Application (2021-2032) Figure 58. Asia Epoprostenol Sales Share by Application (2021-2032) Figure 59. Asia Epoprostenol Revenue Share by Country (2021-2032) Figure 60. Asia Epoprostenol Sales Share by Country (2021-2032) Figure 61. SAMEA Epoprostenol Revenue Share by Type (2021-2032) Figure 62. SAMEA Epoprostenol Sales Share by Type (2021-2032) Figure 63. SAMEA Epoprostenol Revenue Share by Application (2021-2032) Figure 64. SAMEA Epoprostenol Sales Share by Application (2021-2032) Figure 65. SAMEA Epoprostenol Revenue Share by Country (2021-2032) Figure 66. SAMEA Epoprostenol Sales Share by Country (2021-2032) Figure 67. Epoprostenol Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Epoprostenol Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Epoprostenol
  • Injection Epoprostenol
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Teva Parenteral
  • Merck
  • Glaxosmithkline Inc
  • Bayer AG
  • SteadyMed
  • Sandoz Canada Incorporated
  • Reata Pharmaceuticals
  • Arena Pharmaceuticals
  • Actelion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Epoprostenol Market by Type
  3. 1.2.1 Global Epoprostenol Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Epoprostenol
  5. 1.2.3 Injection Epoprostenol
  6. 1.3 Epoprostenol Market by Application
  7. 1.3.1 Global Epoprostenol Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacy
  9. 1.3.3 Online Pharmacy
  10. 1.3.4 Hospital Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Epoprostenol Market Dynamics
  1. 2.1 Epoprostenol Industry Trends
  2. 2.2 Epoprostenol Industry Drivers
  3. 2.3 Epoprostenol Industry Opportunities and Challenges
  4. 2.4 Epoprostenol Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Epoprostenol Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Epoprostenol Revenue by Region
  3. 3.2.1 Global Epoprostenol Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Epoprostenol Revenue by Region (2021-2026)
  5. 3.2.3 Global Epoprostenol Revenue by Region (2027-2032)
  6. 3.2.4 Global Epoprostenol Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Epoprostenol Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Epoprostenol Sales by Region
  9. 3.4.1 Global Epoprostenol Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Epoprostenol Sales by Region (2021-2026)
  11. 3.4.3 Global Epoprostenol Sales by Region (2027-2032)
  12. 3.4.4 Global Epoprostenol Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Epoprostenol Revenue by Manufacturers
  2. 4.1.1 Global Epoprostenol Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Epoprostenol Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Epoprostenol Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Epoprostenol Sales by Manufacturers
  6. 4.2.1 Global Epoprostenol Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Epoprostenol Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Epoprostenol Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Epoprostenol Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Epoprostenol Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Epoprostenol Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Epoprostenol Manufacturers, Product Type & Application
  13. 4.7 Global Epoprostenol Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Epoprostenol Market CR5 and HHI
  16. 4.8.2 2025 Epoprostenol Tier 1, Tier 2, and Tier 3
5 Epoprostenol Market by Type
  1. 5.1 Global Epoprostenol Revenue by Type
  2. 5.1.1 Global Epoprostenol Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Epoprostenol Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Epoprostenol Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Epoprostenol Sales by Type
  6. 5.2.1 Global Epoprostenol Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Epoprostenol Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Epoprostenol Sales Market Share by Type (2021-2032)
  9. 5.3 Global Epoprostenol Price by Type
6 Epoprostenol Market by Application
  1. 6.1 Global Epoprostenol Revenue by Application
  2. 6.1.1 Global Epoprostenol Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Epoprostenol Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Epoprostenol Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Epoprostenol Sales by Application
  6. 6.2.1 Global Epoprostenol Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Epoprostenol Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Epoprostenol Sales Market Share by Application (2021-2032)
  9. 6.3 Global Epoprostenol Price by Application
7 Company Profiles
  1. 7.1 Teva Parenteral
  2. 7.1.1 Teva Parenteral Company Information
  3. 7.1.2 Teva Parenteral Business Overview
  4. 7.1.3 Teva Parenteral Epoprostenol Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Parenteral Epoprostenol Product Portfolio
  6. 7.1.5 Teva Parenteral Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Epoprostenol Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Epoprostenol Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Glaxosmithkline Inc
  14. 7.3.1 Glaxosmithkline Inc Company Information
  15. 7.3.2 Glaxosmithkline Inc Business Overview
  16. 7.3.3 Glaxosmithkline Inc Epoprostenol Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Glaxosmithkline Inc Epoprostenol Product Portfolio
  18. 7.3.5 Glaxosmithkline Inc Recent Developments
  19. 7.4 Bayer AG
  20. 7.4.1 Bayer AG Company Information
  21. 7.4.2 Bayer AG Business Overview
  22. 7.4.3 Bayer AG Epoprostenol Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer AG Epoprostenol Product Portfolio
  24. 7.4.5 Bayer AG Recent Developments
  25. 7.5 SteadyMed
  26. 7.5.1 SteadyMed Company Information
  27. 7.5.2 SteadyMed Business Overview
  28. 7.5.3 SteadyMed Epoprostenol Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 SteadyMed Epoprostenol Product Portfolio
  30. 7.5.5 SteadyMed Recent Developments
  31. 7.6 Sandoz Canada Incorporated
  32. 7.6.1 Sandoz Canada Incorporated Company Information
  33. 7.6.2 Sandoz Canada Incorporated Business Overview
  34. 7.6.3 Sandoz Canada Incorporated Epoprostenol Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sandoz Canada Incorporated Epoprostenol Product Portfolio
  36. 7.6.5 Sandoz Canada Incorporated Recent Developments
  37. 7.7 Reata Pharmaceuticals
  38. 7.7.1 Reata Pharmaceuticals Company Information
  39. 7.7.2 Reata Pharmaceuticals Business Overview
  40. 7.7.3 Reata Pharmaceuticals Epoprostenol Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Reata Pharmaceuticals Epoprostenol Product Portfolio
  42. 7.7.5 Reata Pharmaceuticals Recent Developments
  43. 7.8 Arena Pharmaceuticals
  44. 7.8.1 Arena Pharmaceuticals Company Information
  45. 7.8.2 Arena Pharmaceuticals Business Overview
  46. 7.8.3 Arena Pharmaceuticals Epoprostenol Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Arena Pharmaceuticals Epoprostenol Product Portfolio
  48. 7.8.5 Arena Pharmaceuticals Recent Developments
  49. 7.9 Actelion
  50. 7.9.1 Actelion Company Information
  51. 7.9.2 Actelion Business Overview
  52. 7.9.3 Actelion Epoprostenol Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Actelion Epoprostenol Product Portfolio
  54. 7.9.5 Actelion Recent Developments
8 North America
  1. 8.1 North America Epoprostenol Market Size by Type
  2. 8.1.1 North America Epoprostenol Revenue by Type (2021-2032)
  3. 8.1.2 North America Epoprostenol Sales by Type (2021-2032)
  4. 8.1.3 North America Epoprostenol Price by Type (2021-2032)
  5. 8.2 North America Epoprostenol Market Size by Application
  6. 8.2.1 North America Epoprostenol Revenue by Application (2021-2032)
  7. 8.2.2 North America Epoprostenol Sales by Application (2021-2032)
  8. 8.2.3 North America Epoprostenol Price by Application (2021-2032)
  9. 8.3 North America Epoprostenol Market Size by Country
  10. 8.3.1 North America Epoprostenol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Epoprostenol Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Epoprostenol Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Epoprostenol Market Size by Type
  2. 9.1.1 Europe Epoprostenol Revenue by Type (2021-2032)
  3. 9.1.2 Europe Epoprostenol Sales by Type (2021-2032)
  4. 9.1.3 Europe Epoprostenol Price by Type (2021-2032)
  5. 9.2 Europe Epoprostenol Market Size by Application
  6. 9.2.1 Europe Epoprostenol Revenue by Application (2021-2032)
  7. 9.2.2 Europe Epoprostenol Sales by Application (2021-2032)
  8. 9.2.3 Europe Epoprostenol Price by Application (2021-2032)
  9. 9.3 Europe Epoprostenol Market Size by Country
  10. 9.3.1 Europe Epoprostenol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Epoprostenol Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Epoprostenol Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Epoprostenol Market Size by Type
  2. 10.1.1 China Epoprostenol Revenue by Type (2021-2032)
  3. 10.1.2 China Epoprostenol Sales by Type (2021-2032)
  4. 10.1.3 China Epoprostenol Price by Type (2021-2032)
  5. 10.2 China Epoprostenol Market Size by Application
  6. 10.2.1 China Epoprostenol Revenue by Application (2021-2032)
  7. 10.2.2 China Epoprostenol Sales by Application (2021-2032)
  8. 10.2.3 China Epoprostenol Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Epoprostenol Market Size by Type
  2. 11.1.1 Asia Epoprostenol Revenue by Type (2021-2032)
  3. 11.1.2 Asia Epoprostenol Sales by Type (2021-2032)
  4. 11.1.3 Asia Epoprostenol Price by Type (2021-2032)
  5. 11.2 Asia Epoprostenol Market Size by Application
  6. 11.2.1 Asia Epoprostenol Revenue by Application (2021-2032)
  7. 11.2.2 Asia Epoprostenol Sales by Application (2021-2032)
  8. 11.2.3 Asia Epoprostenol Price by Application (2021-2032)
  9. 11.3 Asia Epoprostenol Market Size by Country
  10. 11.3.1 Asia Epoprostenol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Epoprostenol Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Epoprostenol Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Epoprostenol Market Size by Type
  2. 12.1.1 SAMEA Epoprostenol Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Epoprostenol Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Epoprostenol Price by Type (2021-2032)
  5. 12.2 SAMEA Epoprostenol Market Size by Application
  6. 12.2.1 SAMEA Epoprostenol Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Epoprostenol Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Epoprostenol Price by Application (2021-2032)
  9. 12.3 SAMEA Epoprostenol Market Size by Country
  10. 12.3.1 SAMEA Epoprostenol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Epoprostenol Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Epoprostenol Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Epoprostenol Value Chain Analysis
  2. 13.1.1 Epoprostenol Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Epoprostenol Production Mode & Process
  6. 13.2 Epoprostenol Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Epoprostenol Distributors
  9. 13.2.3 Epoprostenol Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst